日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV-1 aged over 50 years who are virologically suppressed

在病毒学抑制的50岁以上HIV-1感染者中,换用多替拉韦/拉米夫定治疗的真实世界有效性和安全性

Piñeiro, C; Policarpo, S; Caldas, C; Santos, L; Augusto, I; DiMondi, V P; Serrão, R

P-576. Real-world Experience with the Two-Drug Regimen Dolutegravir/Lamivudine for the Treatment of HIV-1 among Vulnerable People Living with HIV in Canada: Preliminary Results from a Chart Review Study

P-576. 在加拿大,使用多替拉韦/拉米夫定双药方案治疗HIV-1感染弱势群体的真实世界经验:一项病历回顾研究的初步结果

Essex, Ryan; Weldon, Sharon Marie; Huchet, Emmanuelle; Ban, Joann K; Adelakun, Adenike R; Osenenko, Katherine; Hardy, Isabelle; Stewart, Elaine; McKimm, Michael; Fortin, Jean-Francois; Crabtree, Madeleine; Johnston, Karissa; Conway, Brian; DiMondi, V Paul

Hypertension and blood pressure changes with dolutegravir or comparator antiretroviral therapy in randomized trials through 96 weeks

在为期 96 周的随机试验中,多替拉韦或对照抗逆转录病毒疗法对高血压和血压变化的影响

Patel, Parul; Milinkovic, Ana; Grove, Richard; Govan, Lindsay; McKenna, Michael; Wynne, Brian; Henegar, Cassidy; Martinez, Esteban; Dimondi, Paul; Chow, Ken; Payvandi, Nassrin; Jones, Bryn

Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species

一项多中心观察性队列研究评估了第三代头孢菌素治疗肠杆菌、沙雷氏菌和柠檬酸杆菌属引起的血流感染的疗效

Derrick, Caroline; Bookstaver, P Brandon; Lu, Zhiqiang K; Bland, Christopher M; King, S Travis; Stover, Kayla R; Rumley, Kathey; MacVane, Shawn H; Swindler, Jenna; Kincaid, Scott; Branan, Trisha; Cluck, David; Britt, Benjamin; Pillinger, Kelly E; Jones, Bruce M; Fleming, Virginia; DiMondi, V Paul; Estrada, Sandy; Crane, Brad; Odle, Brian; Al-Hasan, Majdi N; Justo, Julie Ann

"The Farmer and the Cowman Should be Friends": Surviving a Curricular Revision Through Interprofessional Cooperation

“农夫和牧牛人应该成为朋友”:通过跨专业合作应对课程改革

Bloom, Timothy J; DiMondi, V Paul

Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

重点关注新型氟喹诺酮类药物 JNJ-Q2,用于治疗社区获得性细菌性肺炎和急性细菌性皮肤及皮肤结构感染。

Jones, Travis M; Johnson, Steven W; DiMondi, V Paul; Wilson, Dustin T

Role of isavuconazole in the treatment of invasive fungal infections

伊沙康唑在治疗侵袭性真菌感染中的作用

Wilson, Dustin T; Dimondi, V Paul; Johnson, Steven W; Jones, Travis M; Drew, Richard H